These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3960947)

  • 1. [Preparations of matrix tablets from a polyacrylate base].
    Mank R; Zessin G; Fahr F
    Pharmazie; 1986 Jan; 41(1):42-4. PubMed ID: 3960947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preparation of preoral sustained-release preparations with a base of biodegradable polymers. 3. Preparation of matrix tablets with a base of poly-3-hydroxybutyric acid].
    Mank R; Kala H; Richter M; Babel W; Sattler K
    Pharmazie; 1989 Aug; 44(8):545-7. PubMed ID: 2594825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preparation of oral sustained-action preparations with a base of biologically degradable polymers. 2. Preparation of matrix tablets with a base of polylactic acid].
    Mank R; Kala H; Richter M
    Pharmazie; 1989 May; 44(5):328-30. PubMed ID: 2772012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained release isoniazid tablets. I--Formulation and in vitro evaluation.
    Bulut-Oner F; Capan Y; Kas S; Oner L; Hincal AA
    Farmaco; 1989; 44(7-8):739-52. PubMed ID: 2590371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theophylline loaded gastroretentive floating tablets based on hydrophilic polymers: preparation and in vitro evaluation.
    Khan F; Ibn Razzak SM; Khan ZR; Azad MA; Chowdhury JA; Reza S
    Pak J Pharm Sci; 2009 Apr; 22(2):155-61. PubMed ID: 19339225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
    Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
    Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug release behaviour from methyl methacrylate-starch matrix tablets: effect of polymer moisture content.
    Bravo-Osuna I; Ferrero C; Jiménez-Castellanos MR
    Eur J Pharm Biopharm; 2008 May; 69(1):285-93. PubMed ID: 17997292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preparation of peroral delayed-action drug forms using biological polymers as the base. 4. Preparation of erosion tablets with a base of starch hydrolysis products].
    Mank R; Kala H; Lorenz A
    Pharmazie; 1989 Sep; 44(9):617-8. PubMed ID: 2608707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained release phenylpropanolamine hydrochloride from ATO 888 matrix.
    Perez MA; Ghaly ES; Marti A
    P R Health Sci J; 1993 Dec; 12(4):263-7. PubMed ID: 8140204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The factors influencing metoprolol succinate release from hydroxypropyl methylcellulose matrix tablet].
    Huang G; Wang R; Wang D; Zhang Z; Deng S
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Jun; 23(3):587-91. PubMed ID: 16856395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation of sustained - release lithium carbonate matrix tablets: influence of hydrophilic materials on the release rate and in vitro-in vivo evaluation.
    Emami J; Tavakoli N; Movahedian A
    J Pharm Pharm Sci; 2004 Nov; 7(3):338-44. PubMed ID: 15576014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two galactomannans and scleroglucan as matrices for drug delivery: preparation and release studies.
    Coviello T; Alhaique F; Dorigo A; Matricardi P; Grassi M
    Eur J Pharm Biopharm; 2007 May; 66(2):200-9. PubMed ID: 17156985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of channeling agents on the release pattern of theophylline from kollidon SR based matrix tablets.
    Ibn Razzak MS; Khan F; Hossain M; Khan MZ; Azad MA; Reza MS
    Pak J Pharm Sci; 2009 Jul; 22(3):303-7. PubMed ID: 19553179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preparation of ondansetron hydrochloride sustained-release tablet evaluation of its and drug release behavior in vitro].
    Zhang Y; Huang G; Yu Y; Han J; Yu P
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Jun; 23(3):597-600, 614. PubMed ID: 16856397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study on maize proteins as a potential new tablet excipient.
    Georget DM; Barker SA; Belton PS
    Eur J Pharm Biopharm; 2008 Jun; 69(2):718-26. PubMed ID: 18294824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Citric acid monohydrate as a release-modifying agent in melt extruded matrix tablets.
    Schilling SU; Bruce CD; Shah NH; Malick AW; McGinity JW
    Int J Pharm; 2008 Sep; 361(1-2):158-68. PubMed ID: 18582547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC.
    Shoaib MH; Tazeen J; Merchant HA; Yousuf RI
    Pak J Pharm Sci; 2006 Apr; 19(2):119-24. PubMed ID: 16751122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generalized regression neural networks in prediction of drug stability.
    Ibrić S; Jovanović M; Djurić Z; Parojcić J; Solomun L; Lucić B
    J Pharm Pharmacol; 2007 May; 59(5):745-50. PubMed ID: 17524242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained-release tablets of indomethacin-loaded microcapsules: preparation, in vitro and in vivo characterization.
    Lu B; Wen R; Yang H; He Y
    Int J Pharm; 2007 Mar; 333(1-2):87-94. PubMed ID: 17081709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.